Global Endocrine System Drugs Market Insights, Forecast to 2025
- QYR2790250
- 119 Pages
- October 2018
- Pharmaceuticals
This report studies the global market size of Endocrine System Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Endocrine System Drugs in these regions.
This research report categorizes the global Endocrine System Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
The various contributors involved in the value chain of Endocrine System Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Endocrine System Drugs include
Novo Nordisk
Sanofi
Merck
Eli Lilly
AstraZeneca
AbbVie
Market Size Split by Type
Diabetes Drug
Human Growth Hormones
Thyroid Hormone Disorder Drugs
Other
Market Size Split by Application
Hospitals
Clinics
Medical Center
Other
Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Endocrine System Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Endocrine System Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Endocrine System Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Endocrine System Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Endocrine System Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Endocrine System Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Endocrine System Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Study Coverage
1.1 Endocrine System Drugs Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Endocrine System Drugs Market Size Growth Rate by Type
1.4.2 Diabetes Drug
1.4.3 Human Growth Hormones
1.4.4 Thyroid Hormone Disorder Drugs
1.4.5 Other
1.5 Market by Application
1.5.1 Global Endocrine System Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Medical Center
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Endocrine System Drugs Market Size
2.1.1 Global Endocrine System Drugs Revenue 2016-2025
2.1.2 Global Endocrine System Drugs Sales 2016-2025
2.2 Endocrine System Drugs Growth Rate by Regions
2.2.1 Global Endocrine System Drugs Sales by Regions
2.2.2 Global Endocrine System Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Endocrine System Drugs Sales by Manufacturers
3.1.1 Endocrine System Drugs Sales by Manufacturers
3.1.2 Endocrine System Drugs Sales Market Share by Manufacturers
3.1.3 Global Endocrine System Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Endocrine System Drugs Revenue by Manufacturers
3.2.1 Endocrine System Drugs Revenue by Manufacturers (2016-2018)
3.2.2 Endocrine System Drugs Revenue Share by Manufacturers (2016-2018)
3.3 Endocrine System Drugs Price by Manufacturers
3.4 Endocrine System Drugs Manufacturing Base Distribution, Product Types
3.4.1 Endocrine System Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Endocrine System Drugs Product Category
3.4.3 Date of International Manufacturers Enter into Endocrine System Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Endocrine System Drugs Sales by Type
4.2 Global Endocrine System Drugs Revenue by Type
4.3 Endocrine System Drugs Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Endocrine System Drugs Breakdown Data by Application
6 North America
6.1 North America Endocrine System Drugs by Countries
6.1.1 North America Endocrine System Drugs Sales by Countries
6.1.2 North America Endocrine System Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Endocrine System Drugs by Type
6.3 North America Endocrine System Drugs by Application
6.4 North America Endocrine System Drugs by Company
7 Europe
7.1 Europe Endocrine System Drugs by Countries
7.1.1 Europe Endocrine System Drugs Sales by Countries
7.1.2 Europe Endocrine System Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Endocrine System Drugs by Type
7.3 Europe Endocrine System Drugs by Application
7.4 Europe Endocrine System Drugs by Company
8 Asia Pacific
8.1 Asia Pacific Endocrine System Drugs by Countries
8.1.1 Asia Pacific Endocrine System Drugs Sales by Countries
8.1.2 Asia Pacific Endocrine System Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Endocrine System Drugs by Type
8.3 Asia Pacific Endocrine System Drugs by Application
8.4 Asia Pacific Endocrine System Drugs by Company
9 Central & South America
9.1 Central & South America Endocrine System Drugs by Countries
9.1.1 Central & South America Endocrine System Drugs Sales by Countries
9.1.2 Central & South America Endocrine System Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Endocrine System Drugs by Type
9.3 Central & South America Endocrine System Drugs by Application
9.4 Central & South America Endocrine System Drugs by Company
10 Middle East and Africa
10.1 Middle East and Africa Endocrine System Drugs by Countries
10.1.1 Middle East and Africa Endocrine System Drugs Sales by Countries
10.1.2 Middle East and Africa Endocrine System Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Endocrine System Drugs by Type
10.3 Middle East and Africa Endocrine System Drugs by Application
10.4 Middle East and Africa Endocrine System Drugs by Company
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Endocrine System Drugs
11.1.4 Endocrine System Drugs Product Description
11.1.5 Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Endocrine System Drugs
11.2.4 Endocrine System Drugs Product Description
11.2.5 Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Endocrine System Drugs
11.3.4 Endocrine System Drugs Product Description
11.3.5 Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Endocrine System Drugs
11.4.4 Endocrine System Drugs Product Description
11.4.5 Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Endocrine System Drugs
11.5.4 Endocrine System Drugs Product Description
11.5.5 Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Endocrine System Drugs
11.6.4 Endocrine System Drugs Product Description
11.6.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Endocrine System Drugs Raw Material
13.1.2 Endocrine System Drugs Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
Figure Picture of Endocrine System Drugs
Figure Global Endocrine System Drugs Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Endocrine System Drugs Production Market Share by Types (Product Category) in 2017
Figure Diabetes Drug Product Picture
Table Major Manufacturers of Diabetes Drug
Figure Human Growth Hormones Product Picture
Table Major Manufacturers of Human Growth Hormones
Figure Thyroid Hormone Disorder Drugs Product Picture
Table Major Manufacturers of Thyroid Hormone Disorder Drugs
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Endocrine System Drugs Market Size Growth Rate by Application 2018-2025 (K Pcs)
Figure Hospitals
Figure Clinics
Figure Medical Center
Figure Other
Figure Endocrine System Drugs Report Years Considered
Figure Global Endocrine System Drugs Market Size 2016-2025 (Million US$)
Figure Global Endocrine System Drugs Sales 2016-2025 (K Pcs)
Table Global Endocrine System Drugs Market Size by Regions 2016-2025 (K Pcs) & (Million US$)
Table Global Endocrine System Drugs Sales by Regions 2016-2025 (K Pcs)
Table Global Endocrine System Drugs Sales Market Share by Regions 2016-2025
Figure Global Endocrine System Drugs Sales Market Share by Regions 2016-2025
Figure 2017 Global Endocrine System Drugs Sales Market Share by Regions
Table Global Endocrine System Drugs Revenue by Regions 2016-2025 (Million US$)
Table Global Endocrine System Drugs Revenue Market Share by Regions 2016-2025
Figure Global Endocrine System Drugs Revenue Market Share by Regions 2016-2025
Figure 2017 Global Endocrine System Drugs Revenue Market Share by Regions
Table Global Endocrine System Drugs Sales by Manufacturers (2016-2018) (K Pcs)
Table Global Endocrine System Drugs Sales Share by Manufacturers (2016-2018)
Figure Global Endocrine System Drugs Sales Share by Manufacturers in 2017
Table Endocrine System Drugs Revenue by Manufacturers (2016-2018) (Million US$)
Table Endocrine System Drugs Revenue Share by Manufacturers (2016-2018)
Figure Endocrine System Drugs Value Share by Manufacturers in 2017
Table Global Endocrine System Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Endocrine System Drugs Price (2016-2018) (USD/Pcs)
Table Endocrine System Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Endocrine System Drugs Product Category
Table Date of International Manufacturers Enter into Endocrine System Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Endocrine System Drugs Sales by Type (2016-2025) (K Pcs)
Table Global Endocrine System Drugs Sales Share by Type (2016-2025)
Figure Global Endocrine System Drugs Sales Market Share by Type (2016-2025)
Figure Global Endocrine System Drugs Sales Market Share by Type in 2017
Table Global Endocrine System Drugs Revenue by Type (2016-2025) (Million US$)
Table Global Endocrine System Drugs Revenue Share by Type (2016-2025)
Figure Global Endocrine System Drugs Revenue Market Share by Type (2016-2025)
Figure Global Endocrine System Drugs Revenue Market Share by Type in 2017
Table Endocrine System Drugs Price by Type 2013-2018 (USD/Pcs)
Table Global Endocrine System Drugs Sales by Application (2016-2025) (K Pcs)
Table Global Endocrine System Drugs Sales Share by Application (2016-2025)
Figure Global Sales Endocrine System Drugs Market Share by Application (2016-2025)
Figure Global Sales Endocrine System Drugs Market Share by Application (2016-2025)
Figure North America Endocrine System Drugs Sales Growth Rate 2016-2025 (K Pcs)
Figure North America Endocrine System Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table North America Endocrine System Drugs Sales by Countries (2016-2025) (K Pcs)
Table North America Endocrine System Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 North America Endocrine System Drugs Sales Market Share by Countries
Table North America Endocrine System Drugs Revenue by Countries (2016-2025) (Million US$)
Table North America Endocrine System Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Endocrine System Drugs Revenue Market Share by Countries
Figure United States Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure United States Endocrine System Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Canada Endocrine System Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Mexico Endocrine System Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table North America Endocrine System Drugs Sales by Type (2016-2025) (K Pcs)
Table North America Endocrine System Drugs Sales Market Share by Type (2016-2025)
Figure 2017 North America Endocrine System Drugs Market Share by Type
Table North America Endocrine System Drugs Sales by Application (2016-2025) (K Pcs)
Table North America Endocrine System Drugs Sales Market Share by Application (2016-2025)
Figure 2017 North America Endocrine System Drugs Market Share by Application
Table North America Endocrine System Drugs Sales by Company (2016-2018) (K Pcs)
Table North America Endocrine System Drugs Sales Market Share by Company (2016-2018)
Figure North America Endocrine System Drugs Sales Market Share by Company in 2017
Figure Europe Endocrine System Drugs Sales Growth Rate 2016-2025 (K Pcs)
Figure Europe Endocrine System Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Endocrine System Drugs Sales by Countries (2016-2025) (K Pcs)
Table Europe Endocrine System Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Endocrine System Drugs Sales Market Share by Countries
Table Europe Endocrine System Drugs Revenue by Countries (2016-2025) (Million US$)
Table Europe Endocrine System Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Endocrine System Drugs Revenue Market Share by Countries
Figure Germany Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Germany Endocrine System Drugs Revenue Growth Rate (2016-2025) (K Pcs)
Figure France Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure France Endocrine System Drugs Revenue Growth Rate (2016-2025) (K Pcs)
Figure UK Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure UK Endocrine System Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Italy Endocrine System Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Russia Endocrine System Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Endocrine System Drugs Sales by Type (2016-2025) (K Pcs)
Table Europe Endocrine System Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Europe Endocrine System Drugs Market Share by Type
Table Europe Endocrine System Drugs Sales by Application (2016-2025) (K Pcs)
Table Europe Endocrine System Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Europe Endocrine System Drugs Market Share by Application
Table Europe Endocrine System Drugs Sales by Company (2016-2018) (K Pcs)
Table Europe Endocrine System Drugs Sales Market Share by Company (2016-2018)
Figure Europe Endocrine System Drugs Sales Market Share by Company in 2017
Figure Asia Pacific Endocrine System Drugs Sales Growth Rate 2016-2025 (K Pcs)
Figure Asia Pacific Endocrine System Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Endocrine System Drugs Sales by Countries (2016-2025) (K Pcs)
Table Asia Pacific Endocrine System Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Endocrine System Drugs Sales Market Share by Countries
Table Asia Pacific Endocrine System Drugs Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Endocrine System Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Endocrine System Drugs Revenue Market Share by Countries
Figure China Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure China Endocrine System Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Japan Endocrine System Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Korea Endocrine System Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure India Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure India Endocrine System Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Australia Endocrine System Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Indonesia Endocrine System Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Malaysia Endocrine System Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Philippines Endocrine System Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Thailand Endocrine System Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Vietnam Endocrine System Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Singapore Endocrine System Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Endocrine System Drugs Sales by Type (2016-2025) (K Pcs)
Table Asia Pacific Endocrine System Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Endocrine System Drugs Market Share by Type
Table Asia Pacific Endocrine System Drugs Sales by Application (2016-2025) (K Pcs)
Table Asia Pacific Endocrine System Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Endocrine System Drugs Market Share by Application
Table Asia Pacific Endocrine System Drugs Sales by Company (2016-2018) (K Pcs)
Table Asia Pacific Endocrine System Drugs Sales Market Share by Company (2016-2018)
Figure Asia Pacific Endocrine System Drugs Sales Market Share by Company in 2017
Figure Central & South America Endocrine System Drugs Sales Growth Rate 2016-2025 (K Pcs)
Figure Central & South America Endocrine System Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Endocrine System Drugs Sales by Countries (2016-2025) (K Pcs)
Table Central & South America Endocrine System Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Endocrine System Drugs Sales Market Share by Countries
Table Central & South America Endocrine System Drugs Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Endocrine System Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Endocrine System Drugs Revenue Market Share by Countries
Figure Brazil Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Brazil Endocrine System Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Argentina Endocrine System Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Endocrine System Drugs Sales by Type (2016-2025) (K Pcs)
Table Central & South America Endocrine System Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Endocrine System Drugs Market Share by Type
Table Central & South America Endocrine System Drugs Sales by Application (2016-2025) (K Pcs)
Table Central & South America Endocrine System Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Endocrine System Drugs Market Share by Application
Table Central & South America Endocrine System Drugs Sales by Company (2016-2018) (K Pcs)
Table Central & South America Endocrine System Drugs Sales Market Share by Company (2016-2018)
Figure Central & South America Endocrine System Drugs Sales Market Share by Company in 2017
Figure Middle East and Africa Endocrine System Drugs Sales Growth Rate 2016-2025 (K Pcs)
Figure Middle East and Africa Endocrine System Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Endocrine System Drugs Sales by Countries (2016-2025) (K Pcs)
Table Middle East and Africa Endocrine System Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Endocrine System Drugs Sales Market Share by Countries
Table Middle East and Africa Endocrine System Drugs Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Endocrine System Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Endocrine System Drugs Revenue Market Share by Countries
Figure GCC Countries Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure GCC Countries Endocrine System Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Turkey Endocrine System Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Egypt Endocrine System Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Endocrine System Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure South Africa Endocrine System Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Endocrine System Drugs Sales by Type (2016-2025) (K Pcs)
Table Middle East and Africa Endocrine System Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Endocrine System Drugs Market Share by Type
Table Middle East and Africa Endocrine System Drugs Sales by Application (2016-2025) (K Pcs)
Table Middle East and Africa Endocrine System Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Endocrine System Drugs Market Share by Application
Table Middle East and Africa Endocrine System Drugs Sales by Company (2016-2018) (K Pcs)
Table Middle East and Africa Endocrine System Drugs Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Endocrine System Drugs Sales Market Share by Company in 2017
Table Novo Nordisk Company Details
Table Novo Nordisk Endocrine System Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Novo Nordisk Recent Development
Table Sanofi Company Details
Table Sanofi Endocrine System Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Sanofi Recent Development
Table Merck Company Details
Table Merck Endocrine System Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Merck Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Endocrine System Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Eli Lilly Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Endocrine System Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table AstraZeneca Recent Development
Table AbbVie Company Details
Table AbbVie Endocrine System Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table AbbVie Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Endocrine System Drugs Value Chain
Table Typical Suppliers of Key Endocrine System Drugs Raw Material
Table Endocrine System Drugs Customers List
Table Endocrine System Drugs Sales Channels
Table Endocrine System Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
